- Home
- FOF vs XOMA Comparison
FOF vs XOMA Comparison
Compare FOF & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOF
- XOMA
- Stock Information
- Founded
- FOF 2006
- XOMA 1981
- Country
- FOF United States
- XOMA United States
- Employees
- FOF N/A
- XOMA N/A
- Industry
- FOF Investment Managers
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- FOF Finance
- XOMA Health Care
- Exchange
- FOF Nasdaq
- XOMA Nasdaq
- Market Cap
- FOF 354.8M
- XOMA 330.2M
- IPO Year
- FOF N/A
- XOMA N/A
- Fundamental
- Price
- FOF $13.12
- XOMA $31.37
- Analyst Decision
- FOF
- XOMA Strong Buy
- Analyst Count
- FOF 0
- XOMA 2
- Target Price
- FOF N/A
- XOMA $69.50
- AVG Volume (30 Days)
- FOF 58.7K
- XOMA 35.8K
- Earning Date
- FOF 01-01-0001
- XOMA 08-13-2025
- Dividend Yield
- FOF 9.07%
- XOMA N/A
- EPS Growth
- FOF N/A
- XOMA N/A
- EPS
- FOF N/A
- XOMA N/A
- Revenue
- FOF N/A
- XOMA $44,952,000.00
- Revenue This Year
- FOF N/A
- XOMA $70.91
- Revenue Next Year
- FOF N/A
- XOMA $14.00
- P/E Ratio
- FOF N/A
- XOMA N/A
- Revenue Growth
- FOF N/A
- XOMA 194.98
- 52 Week Low
- FOF $9.59
- XOMA $18.35
- 52 Week High
- FOF $11.75
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- FOF 73.76
- XOMA 68.22
- Support Level
- FOF $12.90
- XOMA $25.15
- Resistance Level
- FOF $13.05
- XOMA $33.15
- Average True Range (ATR)
- FOF 0.09
- XOMA 1.74
- MACD
- FOF 0.01
- XOMA 0.59
- Stochastic Oscillator
- FOF 97.30
- XOMA 80.37
About FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.